KLRS

NASDAQStock

Kalaris Therapeutics Inc

$8.69-0.48 (-5.23%)

52-Week Range

$2.27

$11.47

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

-0.14

Volume

28.4K

Avg Volume

52.2K

Performance

+2.12%

+7.88%

+147.17%

YTD

+10.48%

-20.05%

Price Chart

ETF Exposure

KLRS is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
SURI	Simplify Propel Opportunities ETF	1.07%	87,426	$802K	$76.9M	2.82%
IWC	iShares Micro-Cap ETF	0.01%	13,395	$123K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	72,619	$645K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	8	$104	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	310	$4K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$18	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	176,727	$1.6M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	929	$11K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	80	$963	$1.29B	0.17%

About KLRS ETF Exposure

Kalaris Therapeutics Inc (KLRS) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $8.69. Investors can gain exposure to KLRS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KLRS, sorted by portfolio weight.